The IMID Forum

Author Interview: Dr Jürgen Rech, 2024

Apr 4, 2024
Guest
Jürgen Rech
Dr Jürgen Rech discusses inhibiting inflammation to prevent rheumatoid arthritis, early intervention strategies, efficacy of abatacept in delaying onset of RA, role of ACTPA antibodies, smoking as a risk factor, biomarkers, and treatment benefits lasting up to 24 months.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Early Intervention Strategies in Preventing Rheumatoid Arthritis Progression
02:47 • 11min
3
Efficacy of Abatacept in Delaying Onset of Rheumatoid Arthritis
13:39 • 5min
4
Understanding the Role of ACTPA Antibodies in Rheumatoid Arthritis Treatment
18:37 • 9min
5
Discussion on Smoking as a Risk Factor, Biomarkers, and Clinical Trial Selection in RA Patients
28:05 • 2min
6
Duration of Treatment Benefits and Recent Study Findings
30:23 • 2min